Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
Barriers to atrial fibrillation ablation during mitral valve surgery.

The Journal of thoracic and cardiovascular surgery

Mehaffey JH, Charles EJ, Berens M, Clark MJ, Bond C, Fonner CE, Kron I, Gelijns AC, Miller MA, Sarin E, Romano M, Prager R, Badhwar V, Ailawadi G.
PMID: 33840467
J Thorac Cardiovasc Surg. 2021 Mar 17; doi: 10.1016/j.jtcvs.2021.03.039. Epub 2021 Mar 17.

BACKGROUND: Nearly 40% of patients with atrial fibrillation (AF) undergoing mitral valve surgery do not receive concomitant ablation despite societal guidelines. We assessed barriers to implementation of this evidence-based practice through a survey of cardiac surgeons in 2 statewide...

Cite
Mehaffey JH, Charles EJ, Berens M, et al. Barriers to atrial fibrillation ablation during mitral valve surgery. J Thorac Cardiovasc Surg. 2021;doi: 10.1016/j.jtcvs.2021.03.039.
Mehaffey, J. H., Charles, E. J., Berens, M., Clark, M. J., Bond, C., Fonner, C. E., Kron, I., Gelijns, A. C., Miller, M. A., Sarin, E., Romano, M., Prager, R., Badhwar, V., & Ailawadi, G. (2021). Barriers to atrial fibrillation ablation during mitral valve surgery. The Journal of thoracic and cardiovascular surgery, . https://doi.org/10.1016/j.jtcvs.2021.03.039
Mehaffey, J Hunter, et al. "Barriers to atrial fibrillation ablation during mitral valve surgery." The Journal of thoracic and cardiovascular surgery vol. (2021). doi: https://doi.org/10.1016/j.jtcvs.2021.03.039
Mehaffey JH, Charles EJ, Berens M, Clark MJ, Bond C, Fonner CE, Kron I, Gelijns AC, Miller MA, Sarin E, Romano M, Prager R, Badhwar V, Ailawadi G. Barriers to atrial fibrillation ablation during mitral valve surgery. J Thorac Cardiovasc Surg. 2021 Mar 17; doi: 10.1016/j.jtcvs.2021.03.039. Epub 2021 Mar 17. PMID: 33840467; PMCID: PMC8446105.
Copy Download .nbib Format: NLM
Rationale and Design of a Randomized Trial Evaluating an External Support Device for Saphenous Vein Coronary Grafts.

American heart journal

Bagiella E, Puskas JD, Moskowitz AJ, Gelijns AC, Alexander JH, Narula J, Smith PK, Hutcheson K, Chang HL, Gammie JS, Iribarne A, Marks ME, Vengrenyuk Y, Yasumura K, Raymond S, Taylor BS, Yarden O, Orion E, Dagenais F, Ailawadi G, Chu MWA, Gupta L, Levitan RG, Williams JB, Crestanello JA, Jessup M, Rose EA, Scavo V, Acker MA, Gillinov M, O'Gara PT, Voisine P, Mack MJ, Goldstein DJ.
PMID: 34936861
Am Heart J. 2021 Dec 19; doi: 10.1016/j.ahj.2021.12.009. Epub 2021 Dec 19.

BACKGROUND: Coronary artery bypass grafting (CABG) is the most common revascularization approach for the treatment of multi-vessel coronary artery disease. While the internal mammary artery is nearly universally used to bypass the left anterior descending coronary artery, autologous saphenous...

Cite
Bagiella E, Puskas JD, Moskowitz AJ, et al. Rationale and Design of a Randomized Trial Evaluating an External Support Device for Saphenous Vein Coronary Grafts. Am Heart J. 2021;doi: 10.1016/j.ahj.2021.12.009.
Bagiella, E., Puskas, J. D., Moskowitz, A. J., Gelijns, A. C., Alexander, J. H., Narula, J., Smith, P. K., Hutcheson, K., Chang, H. L., Gammie, J. S., Iribarne, A., Marks, M. E., Vengrenyuk, Y., Yasumura, K., Raymond, S., Taylor, B. S., Yarden, O., Orion, E., Dagenais, F., Ailawadi, G., Chu, M. W. A., Gupta, L., Levitan, R. G., Williams, J. B., Crestanello, J. A., Jessup, M., Rose, E. A., Scavo, V., Acker, M. A., Gillinov, M., O'Gara, P. T., Voisine, P., Mack, M. J., & Goldstein, D. J. (2021). Rationale and Design of a Randomized Trial Evaluating an External Support Device for Saphenous Vein Coronary Grafts. American heart journal, . https://doi.org/10.1016/j.ahj.2021.12.009
Bagiella, Emilia, et al. "Rationale and Design of a Randomized Trial Evaluating an External Support Device for Saphenous Vein Coronary Grafts." American heart journal vol. (2021). doi: https://doi.org/10.1016/j.ahj.2021.12.009
Bagiella E, Puskas JD, Moskowitz AJ, Gelijns AC, Alexander JH, Narula J, Smith PK, Hutcheson K, Chang HL, Gammie JS, Iribarne A, Marks ME, Vengrenyuk Y, Yasumura K, Raymond S, Taylor BS, Yarden O, Orion E, Dagenais F, Ailawadi G, Chu MWA, Gupta L, Levitan RG, Williams JB, Crestanello JA, Jessup M, Rose EA, Scavo V, Acker MA, Gillinov M, O'Gara PT, Voisine P, Mack MJ, Goldstein DJ. Rationale and Design of a Randomized Trial Evaluating an External Support Device for Saphenous Vein Coronary Grafts. Am Heart J. 2021 Dec 19; doi: 10.1016/j.ahj.2021.12.009. Epub 2021 Dec 19. PMID: 34936861.
Copy Download .nbib Format: NLM
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).

medRxiv : the preprint server for health sciences

Murray DD, Babiker AG, Baker JV, Barkauskas CE, Brown SM, Chang CC, Davey VJ, Gelijns AC, Ginde AA, Grund B, Higgs E, Hudson F, Kan VL, Lane HC, Murray TA, Paredes R, Parmar MKB, Pett S, Phillips AN, Polizzotto MN, Reilly C, Sandkovsky U, Sharma S, Teitelbaum M, Thompson BT, Young BE, Neaton JD, Lundgren JD.
PMID: 33215168
medRxiv. 2021 Apr 08; doi: 10.1101/2020.11.08.20227876.

BACKGROUND: Safe and effective therapies for COVID-19 are urgently needed. In order to meet this need, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership initiated the Therapeutics for Inpatients with COVID-19 (TICO). TICO is a multi-arm, multi-stage...

Cite
Murray DD, Babiker AG, Baker JV, et al. Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). medRxiv. 2021;doi: 10.1101/2020.11.08.20227876.
Murray, D. D., Babiker, A. G., Baker, J. V., Barkauskas, C. E., Brown, S. M., Chang, C. C., Davey, V. J., Gelijns, A. C., Ginde, A. A., Grund, B., Higgs, E., Hudson, F., Kan, V. L., Lane, H. C., Murray, T. A., Paredes, R., Parmar, M. K. B., Pett, S., Phillips, A. N., Polizzotto, M. N., Reilly, C., Sandkovsky, U., Sharma, S., Teitelbaum, M., Thompson, B. T., Young, B. E., Neaton, J. D., & Lundgren, J. D. (2021). Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.11.08.20227876
Murray, Daniel D, et al. "Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2020.11.08.20227876
Murray DD, Babiker AG, Baker JV, Barkauskas CE, Brown SM, Chang CC, Davey VJ, Gelijns AC, Ginde AA, Grund B, Higgs E, Hudson F, Kan VL, Lane HC, Murray TA, Paredes R, Parmar MKB, Pett S, Phillips AN, Polizzotto MN, Reilly C, Sandkovsky U, Sharma S, Teitelbaum M, Thompson BT, Young BE, Neaton JD, Lundgren JD. Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). medRxiv. 2021 Apr 08; doi: 10.1101/2020.11.08.20227876. PMID: 33215168; PMCID: PMC7675662.
Copy Download .nbib Format: NLM
Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.

The New England journal of medicine

Gammie JS, Chu MWA, Falk V, Overbey JR, Moskowitz AJ, Gillinov M, Mack MJ, Voisine P, Krane M, Yerokun B, Bowdish ME, Conradi L, Bolling SF, Miller MA, Taddei-Peters WC, Jeffries NO, Parides MK, Weisel R, Jessup M, Rose EA, Mullen JC, Raymond S, Moquete EG, O'Sullivan K, Marks ME, Iribarne A, Beyersdorf F, Borger MA, Geirsson A, Bagiella E, Hung J, Gelijns AC, O'Gara PT, Ailawadi G.
PMID: 34767705
N Engl J Med. 2021 Nov 13; doi: 10.1056/NEJMoa2115961. Epub 2021 Nov 13.

BACKGROUND: Tricuspid regurgitation is common in patients with severe degenerative mitral regurgitation. However, the evidence base is insufficient to inform a decision about whether to perform tricuspid-valve repair during mitral-valve surgery in patients who have moderate tricuspid regurgitation or...

Cite
Gammie JS, Chu MWA, Falk V, et al. Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. N Engl J Med. 2021;doi: 10.1056/NEJMoa2115961.
Gammie, J. S., Chu, M. W. A., Falk, V., Overbey, J. R., Moskowitz, A. J., Gillinov, M., Mack, M. J., Voisine, P., Krane, M., Yerokun, B., Bowdish, M. E., Conradi, L., Bolling, S. F., Miller, M. A., Taddei-Peters, W. C., Jeffries, N. O., Parides, M. K., Weisel, R., Jessup, M., Rose, E. A., Mullen, J. C., Raymond, S., Moquete, E. G., O'Sullivan, K., Marks, M. E., Iribarne, A., Beyersdorf, F., Borger, M. A., Geirsson, A., Bagiella, E., Hung, J., Gelijns, A. C., O'Gara, P. T., Ailawadi, G. (2021). Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. The New England journal of medicine, . https://doi.org/10.1056/NEJMoa2115961
Gammie, James S, et al. "Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation." The New England journal of medicine vol. (2021). doi: https://doi.org/10.1056/NEJMoa2115961
Gammie JS, Chu MWA, Falk V, Overbey JR, Moskowitz AJ, Gillinov M, Mack MJ, Voisine P, Krane M, Yerokun B, Bowdish ME, Conradi L, Bolling SF, Miller MA, Taddei-Peters WC, Jeffries NO, Parides MK, Weisel R, Jessup M, Rose EA, Mullen JC, Raymond S, Moquete EG, O'Sullivan K, Marks ME, Iribarne A, Beyersdorf F, Borger MA, Geirsson A, Bagiella E, Hung J, Gelijns AC, O'Gara PT, Ailawadi G. Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. N Engl J Med. 2021 Nov 13; doi: 10.1056/NEJMoa2115961. Epub 2021 Nov 13. PMID: 34767705.
Copy Download .nbib Format: NLM
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).

Clinical trials (London, England)

Murray DD, Babiker AG, Baker JV, Barkauskas CE, Brown SM, Chang CC, Davey VJ, Gelijns AC, Ginde AA, Grund B, Higgs E, Hudson F, Kan VL, Lane HC, Murray TA, Paredes R, Parmar MK, Pett S, Phillips AN, Polizzotto MN, Reilly C, Sandkovsky U, Sharma S, Teitelbaum M, Thompson BT, Young BE, Neaton JD, Lundgren JD.
PMID: 34632800
Clin Trials. 2021 Oct 10;17407745211049829. doi: 10.1177/17407745211049829. Epub 2021 Oct 10.

BACKGROUND/AIMS: Safe and effective therapies for COVID-19 are urgently needed. In order to meet this need, the Accelerating COVID-19 Therapeutic Interventions and Vaccines public-private partnership initiated the Therapeutics for Inpatients with COVID-19. Therapeutics for Inpatients with COVID-19 is a...

Cite
Murray DD, Babiker AG, Baker JV, et al. Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). Clin Trials. 2021;17407745211049829doi: 10.1177/17407745211049829.
Murray, D. D., Babiker, A. G., Baker, J. V., Barkauskas, C. E., Brown, S. M., Chang, C. C., Davey, V. J., Gelijns, A. C., Ginde, A. A., Grund, B., Higgs, E., Hudson, F., Kan, V. L., Lane, H. C., Murray, T. A., Paredes, R., Parmar, M. K., Pett, S., Phillips, A. N., Polizzotto, M. N., Reilly, C., Sandkovsky, U., Sharma, S., Teitelbaum, M., Thompson, B. T., Young, B. E., Neaton, J. D., & Lundgren, J. D. (2021). Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). Clinical trials (London, England), 17407745211049829. https://doi.org/10.1177/17407745211049829
Murray, Daniel D, et al. "Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)." Clinical trials (London, England) vol. (2021): 17407745211049829. doi: https://doi.org/10.1177/17407745211049829
Murray DD, Babiker AG, Baker JV, Barkauskas CE, Brown SM, Chang CC, Davey VJ, Gelijns AC, Ginde AA, Grund B, Higgs E, Hudson F, Kan VL, Lane HC, Murray TA, Paredes R, Parmar MK, Pett S, Phillips AN, Polizzotto MN, Reilly C, Sandkovsky U, Sharma S, Teitelbaum M, Thompson BT, Young BE, Neaton JD, Lundgren JD. Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). Clin Trials. 2021 Oct 10;17407745211049829. doi: 10.1177/17407745211049829. Epub 2021 Oct 10. PMID: 34632800.
Copy Download .nbib Format: NLM
Current practice patterns for use of the radial artery for coronary surgery in dedicated centers.

The Journal of thoracic and cardiovascular surgery

Robinson NB, Audisio K, Cancelli G, Masterson Creber RM, Fremes SE, Gelijns AC, Gaudino M.
PMID: 34654559
J Thorac Cardiovasc Surg. 2021 Sep 25; doi: 10.1016/j.jtcvs.2021.09.035. Epub 2021 Sep 25.

No abstract available.

Cite
Robinson NB, Audisio K, Cancelli G, et al. Current practice patterns for use of the radial artery for coronary surgery in dedicated centers. J Thorac Cardiovasc Surg. 2021;doi: 10.1016/j.jtcvs.2021.09.035.
Robinson, N. B., Audisio, K., Cancelli, G., Masterson Creber, R. M., Fremes, S. E., Gelijns, A. C., & Gaudino, M. (2021). Current practice patterns for use of the radial artery for coronary surgery in dedicated centers. The Journal of thoracic and cardiovascular surgery, . https://doi.org/10.1016/j.jtcvs.2021.09.035
Robinson, N Bryce, et al. "Current practice patterns for use of the radial artery for coronary surgery in dedicated centers." The Journal of thoracic and cardiovascular surgery vol. (2021). doi: https://doi.org/10.1016/j.jtcvs.2021.09.035
Robinson NB, Audisio K, Cancelli G, Masterson Creber RM, Fremes SE, Gelijns AC, Gaudino M. Current practice patterns for use of the radial artery for coronary surgery in dedicated centers. J Thorac Cardiovasc Surg. 2021 Sep 25; doi: 10.1016/j.jtcvs.2021.09.035. Epub 2021 Sep 25. PMID: 34654559.
Copy Download .nbib Format: NLM
Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.

The New England journal of medicine

Gammie JS, Chu MWA, Falk V, Overbey JR, Moskowitz AJ, Gillinov M, Mack MJ, Voisine P, Krane M, Yerokun B, Bowdish ME, Conradi L, Bolling SF, Miller MA, Taddei-Peters WC, Jeffries NO, Parides MK, Weisel R, Jessup M, Rose EA, Mullen JC, Raymond S, Moquete EG, O'Sullivan K, Marks ME, Iribarne A, Beyersdorf F, Borger MA, Geirsson A, Bagiella E, Hung J, Gelijns AC, O'Gara PT, Ailawadi G.
PMID: 34767705
N Engl J Med. 2021 Nov 13; doi: 10.1056/NEJMoa2115961. Epub 2021 Nov 13.

BACKGROUND: Tricuspid regurgitation is common in patients with severe degenerative mitral regurgitation. However, the evidence base is insufficient to inform a decision about whether to perform tricuspid-valve repair during mitral-valve surgery in patients who have moderate tricuspid regurgitation or...

Cite
Gammie JS, Chu MWA, Falk V, et al. Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. N Engl J Med. 2021;doi: 10.1056/NEJMoa2115961.
Gammie, J. S., Chu, M. W. A., Falk, V., Overbey, J. R., Moskowitz, A. J., Gillinov, M., Mack, M. J., Voisine, P., Krane, M., Yerokun, B., Bowdish, M. E., Conradi, L., Bolling, S. F., Miller, M. A., Taddei-Peters, W. C., Jeffries, N. O., Parides, M. K., Weisel, R., Jessup, M., Rose, E. A., Mullen, J. C., Raymond, S., Moquete, E. G., O'Sullivan, K., Marks, M. E., Iribarne, A., Beyersdorf, F., Borger, M. A., Geirsson, A., Bagiella, E., Hung, J., Gelijns, A. C., O'Gara, P. T., Ailawadi, G. (2021). Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. The New England journal of medicine, . https://doi.org/10.1056/NEJMoa2115961
Gammie, James S, et al. "Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation." The New England journal of medicine vol. (2021). doi: https://doi.org/10.1056/NEJMoa2115961
Gammie JS, Chu MWA, Falk V, Overbey JR, Moskowitz AJ, Gillinov M, Mack MJ, Voisine P, Krane M, Yerokun B, Bowdish ME, Conradi L, Bolling SF, Miller MA, Taddei-Peters WC, Jeffries NO, Parides MK, Weisel R, Jessup M, Rose EA, Mullen JC, Raymond S, Moquete EG, O'Sullivan K, Marks ME, Iribarne A, Beyersdorf F, Borger MA, Geirsson A, Bagiella E, Hung J, Gelijns AC, O'Gara PT, Ailawadi G. Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. N Engl J Med. 2021 Nov 13; doi: 10.1056/NEJMoa2115961. Epub 2021 Nov 13. PMID: 34767705.
Copy Download .nbib Format: NLM
Reply: Reconsider the MitraClip for High-Risk Patients.

Journal of the American College of Cardiology

Chikwe J, O'Gara P, Gelijns A.
PMID: 34857102
J Am Coll Cardiol. 2021 Dec 07;78(23):e295. doi: 10.1016/j.jacc.2021.10.002.

No abstract available.

Cite
Chikwe J, O'Gara P, Gelijns A. Reply: Reconsider the MitraClip for High-Risk Patients. J Am Coll Cardiol. 2021;78(23):e295doi: 10.1016/j.jacc.2021.10.002.
Chikwe, J., O'Gara, P., & Gelijns, A. (2021). Reply: Reconsider the MitraClip for High-Risk Patients. Journal of the American College of Cardiology, 78(23), e295. https://doi.org/10.1016/j.jacc.2021.10.002
Chikwe, Joanna, et al. "Reply: Reconsider the MitraClip for High-Risk Patients." Journal of the American College of Cardiology vol. 78,23 (2021): e295. doi: https://doi.org/10.1016/j.jacc.2021.10.002
Chikwe J, O'Gara P, Gelijns A. Reply: Reconsider the MitraClip for High-Risk Patients. J Am Coll Cardiol. 2021 Dec 07;78(23):e295. doi: 10.1016/j.jacc.2021.10.002. PMID: 34857102.
Copy Download .nbib Format: NLM
Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.

The New England journal of medicine

Gammie JS, Chu MWA, Falk V, Overbey JR, Moskowitz AJ, Gillinov M, Mack MJ, Voisine P, Krane M, Yerokun B, Bowdish ME, Conradi L, Bolling SF, Miller MA, Taddei-Peters WC, Jeffries NO, Parides MK, Weisel R, Jessup M, Rose EA, Mullen JC, Raymond S, Moquete EG, O'Sullivan K, Marks ME, Iribarne A, Beyersdorf F, Borger MA, Geirsson A, Bagiella E, Hung J, Gelijns AC, O'Gara PT, Ailawadi G.
PMID: 34767705
N Engl J Med. 2021 Nov 13; doi: 10.1056/NEJMoa2115961. Epub 2021 Nov 13.

BACKGROUND: Tricuspid regurgitation is common in patients with severe degenerative mitral regurgitation. However, the evidence base is insufficient to inform a decision about whether to perform tricuspid-valve repair during mitral-valve surgery in patients who have moderate tricuspid regurgitation or...

Cite
Gammie JS, Chu MWA, Falk V, et al. Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. N Engl J Med. 2021;doi: 10.1056/NEJMoa2115961.
Gammie, J. S., Chu, M. W. A., Falk, V., Overbey, J. R., Moskowitz, A. J., Gillinov, M., Mack, M. J., Voisine, P., Krane, M., Yerokun, B., Bowdish, M. E., Conradi, L., Bolling, S. F., Miller, M. A., Taddei-Peters, W. C., Jeffries, N. O., Parides, M. K., Weisel, R., Jessup, M., Rose, E. A., Mullen, J. C., Raymond, S., Moquete, E. G., O'Sullivan, K., Marks, M. E., Iribarne, A., Beyersdorf, F., Borger, M. A., Geirsson, A., Bagiella, E., Hung, J., Gelijns, A. C., O'Gara, P. T., Ailawadi, G. (2021). Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. The New England journal of medicine, . https://doi.org/10.1056/NEJMoa2115961
Gammie, James S, et al. "Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation." The New England journal of medicine vol. (2021). doi: https://doi.org/10.1056/NEJMoa2115961
Gammie JS, Chu MWA, Falk V, Overbey JR, Moskowitz AJ, Gillinov M, Mack MJ, Voisine P, Krane M, Yerokun B, Bowdish ME, Conradi L, Bolling SF, Miller MA, Taddei-Peters WC, Jeffries NO, Parides MK, Weisel R, Jessup M, Rose EA, Mullen JC, Raymond S, Moquete EG, O'Sullivan K, Marks ME, Iribarne A, Beyersdorf F, Borger MA, Geirsson A, Bagiella E, Hung J, Gelijns AC, O'Gara PT, Ailawadi G. Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. N Engl J Med. 2021 Nov 13; doi: 10.1056/NEJMoa2115961. Epub 2021 Nov 13. PMID: 34767705.
Copy Download .nbib Format: NLM
Risk for non-home discharge following surgery for ischemic mitral valve disease.

The Journal of thoracic and cardiovascular surgery

Lala A, Chang HL, Liu X, Charles EJ, Yerokun BA, Bowdish ME, Thourani VH, Mack MJ, Miller MA, O'Gara PT, Blackstone EH, Moskowitz AJ, Gelijns AC, Mullen JC, Stevenson LW.
PMID: 32307181
J Thorac Cardiovasc Surg. 2021 Dec;162(6):1769-1778.e7. doi: 10.1016/j.jtcvs.2020.02.084. Epub 2020 Mar 04.

OBJECTIVES: To determine the frequency and risk factors for non-home discharge (NHD) and its association with clinical outcomes and quality of life (QOL) at 1 year following cardiac surgery in patients with ischemic mitral regurgitation (IMR).METHODS: Discharge disposition was...

Cite
Lala A, Chang HL, Liu X, et al. Risk for non-home discharge following surgery for ischemic mitral valve disease. J Thorac Cardiovasc Surg. 2020;162(6):1769-1778.e7doi: 10.1016/j.jtcvs.2020.02.084.
Lala, A., Chang, H. L., Liu, X., Charles, E. J., Yerokun, B. A., Bowdish, M. E., Thourani, V. H., Mack, M. J., Miller, M. A., O'Gara, P. T., Blackstone, E. H., Moskowitz, A. J., Gelijns, A. C., Mullen, J. C., Stevenson, L. W. (2021). Risk for non-home discharge following surgery for ischemic mitral valve disease. The Journal of thoracic and cardiovascular surgery, 162(6), 1769-1778.e7. https://doi.org/10.1016/j.jtcvs.2020.02.084
Lala, Anuradha, et al. "Risk for non-home discharge following surgery for ischemic mitral valve disease." The Journal of thoracic and cardiovascular surgery vol. 162,6 (2021): 1769-1778.e7. doi: https://doi.org/10.1016/j.jtcvs.2020.02.084
Lala A, Chang HL, Liu X, Charles EJ, Yerokun BA, Bowdish ME, Thourani VH, Mack MJ, Miller MA, O'Gara PT, Blackstone EH, Moskowitz AJ, Gelijns AC, Mullen JC, Stevenson LW. Risk for non-home discharge following surgery for ischemic mitral valve disease. J Thorac Cardiovasc Surg. 2021 Dec;162(6):1769-1778.e7. doi: 10.1016/j.jtcvs.2020.02.084. Epub 2020 Mar 04. PMID: 32307181; PMCID: PMC7874266.
Copy Download .nbib Format: NLM
The Emergence of Population Health in US Academic Medicine: A Qualitative Assessment.

JAMA network open

Gourevitch MN, Curtis LH, Durkin MS, Fagerlin A, Gelijns AC, Platt R, Reininger BM, Wylie-Rosett J, Jones K, Tierney WM.
PMID: 30977857
JAMA Netw Open. 2019 Apr 05;2(4):e192200. doi: 10.1001/jamanetworkopen.2019.2200.

IMPORTANCE: In response to rapidly growing interest in population health, academic medical centers are launching department-level initiatives that focus on this evolving discipline. This trend, with its potential to extend the scope of academic medicine, has not been well...

Cite
Gourevitch MN, Curtis LH, Durkin MS, et al. The Emergence of Population Health in US Academic Medicine: A Qualitative Assessment. JAMA Netw Open. 2019;2(4):e192200doi: 10.1001/jamanetworkopen.2019.2200.
Gourevitch, M. N., Curtis, L. H., Durkin, M. S., Fagerlin, A., Gelijns, A. C., Platt, R., Reininger, B. M., Wylie-Rosett, J., Jones, K., & Tierney, W. M. (2019). The Emergence of Population Health in US Academic Medicine: A Qualitative Assessment. JAMA network open, 2(4), e192200. https://doi.org/10.1001/jamanetworkopen.2019.2200
Gourevitch, Marc N, et al. "The Emergence of Population Health in US Academic Medicine: A Qualitative Assessment." JAMA network open vol. 2,4 (2019): e192200. doi: https://doi.org/10.1001/jamanetworkopen.2019.2200
Gourevitch MN, Curtis LH, Durkin MS, Fagerlin A, Gelijns AC, Platt R, Reininger BM, Wylie-Rosett J, Jones K, Tierney WM. The Emergence of Population Health in US Academic Medicine: A Qualitative Assessment. JAMA Netw Open. 2019 Apr 05;2(4):e192200. doi: 10.1001/jamanetworkopen.2019.2200. PMID: 30977857; PMCID: PMC6481447.
Copy Download .nbib Format: NLM
What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic?.

Annals of the American Thoracic Society

Brown SM, Peltan ID, Barkauskas C, Rogers AJ, Kan V, Gelijns A, Thompson BT.
PMID: 34288834
Ann Am Thorac Soc. 2021 Dec;18(12):1948-1950. doi: 10.1513/AnnalsATS.202105-534PS.

No abstract available.

Cite
Brown SM, Peltan ID, Barkauskas C, et al. What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic?. Ann Am Thorac Soc. 2021;18(12):1948-1950doi: 10.1513/AnnalsATS.202105-534PS.
Brown, S. M., Peltan, I. D., Barkauskas, C., Rogers, A. J., Kan, V., Gelijns, A., & Thompson, B. T. (2021). What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic?. Annals of the American Thoracic Society, 18(12), 1948-1950. https://doi.org/10.1513/AnnalsATS.202105-534PS
Brown, Samuel M, et al. "What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic?." Annals of the American Thoracic Society vol. 18,12 (2021): 1948-1950. doi: https://doi.org/10.1513/AnnalsATS.202105-534PS
Brown SM, Peltan ID, Barkauskas C, Rogers AJ, Kan V, Gelijns A, Thompson BT. What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic?. Ann Am Thorac Soc. 2021 Dec;18(12):1948-1950. doi: 10.1513/AnnalsATS.202105-534PS. PMID: 34288834; PMCID: PMC8641820.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries